Literature DB >> 49087

Heparin cofactor activity measured with an amidolytic method.

O R Odegard, M Lie, U Abildgaard.   

Abstract

Mesh：

Substances：

Year:  1975        PMID： 49087     DOI： 10.1016/0049-3848(75)90078-x

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  32 in total

1.  Gamma irradiated blood samples: unsuitability for haemostatic evaluation of high risk patients.

Authors:  D Cummins; T Southee; K Walshe; I J Mackie; S J Machin
Journal:  J Clin Pathol       Date:  1989-06       Impact factor: 3.411

2.  Degradation of basement membrane laminin by human neutrophil elastase and cathepsin G.

Authors:  L W Heck; W D Blackburn; M H Irwin; D R Abrahamson
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

3.  Plasma levels of human granulocytic elastase alpha 1-proteinase inhibitor complex (E-alpha 1-PI) in leukemia.

Authors:  E Hiller; M Jochum
Journal:  Blut       Date:  1984-05

4.  Arginine residues are critical for the heparin-cofactor activity of antithrombin III.

Authors:  A M Jorgensen; C L Borders; W W Fish
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

5.  Effect of danazol on the biochemical abnormality of inherited antithrombin III deficiency.

Authors:  A J Fairfax; R M Ibbotson
Journal:  Thorax       Date:  1985-09       Impact factor: 9.139

6.  Antithrombin III in patients on long-term oral anticoagulants.

Authors:  H Bull; I Mackie; M Brozović; D Woodings
Journal:  J Clin Pathol       Date:  1980-12       Impact factor: 3.411

7.  Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.

Authors:  J F Eidt; P Allison; S Noble; J Ashton; P Golino; J McNatt; L M Buja; J T Willerson
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

8.  [Effect of heparin and ASA on changes of haemostasis induced by venous occlusion (author's transl)].

Authors:  H Vinazzer; D Loew
Journal:  Blut       Date:  1978-05-18

9.  Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.

Authors:  A Girolami; F Fabris; G Cappellato; L Sainati; G Boeri
Journal:  Blut       Date:  1983-08

10.  Usefulness of antithrombin III and alpha 2-plasmin inhibitor in early differentiation of fulminant hepatitis and severe form of acute hepatitis.

Authors:  S Sato; A Murakami; T Yoshida; T Kashiwabara; K Suzuki; I Kaito
Journal:  Gastroenterol Jpn       Date:  1983-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.